The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian ...

Colossal Biosciences announced a new partnership with the University of Tasmania to combat devil facial tumour disease, a contagious cancer that has devastated the Tasmanian devil since it was first ...

The Trump administration has proposed what experts are calling “an unprecedented shift” in the way the federal government determines how to distribute grant funding.The most significant change ...

A new intranasal DNA vaccine may give the immune system an extra weapon against tuberculosis by targeting bacteria that can ...

I see it often. Hardworking professionals in cafés, airports, or parks hunched over a laptop while carefully dragging their fingers over their PC’s trackpad to navigate some email, project, or alert ...

Northwestern Medicine scientists have discovered that one of the body's most fundamental biological processes—how red blood ...

Scientists have identified targets on the malaria-causing parasite that could be key to developing a universal vaccine against one of humankind's oldest and deadliest diseases. Researchers from Oregon ...

The experimental SchistoShield vaccine triggered strong B-cell and T-cell immune memory in early U.S. and African clinical trials.

For a vaccine to be effective, it must do two things. First, it must trigger an immune response. Second, the vaccine must ...

Dissecting protective versus detrimental immune responses uncovers biomarkers and mechanisms that can inform the rational design and evaluation of live attenuated vaccines against African swine fever ...